USP 797 Postponed
The December 1st implementation date for the new USP General Chapter <797> has been postponed. The current chapter (last revised 2008) will continue to remain in effect until further notice.
Read More
New Packaging & Labeling
If you’ve placed an order recently you may have noticed some changes. HollisterStier Allergy is proud to offer the same quality products with an updated look. Our product packaging and labels have been revamped to meet FDA serialization standards.
HollisterStier Allergy Botanist Led Pollen Walks: Where Classroom Meets Nature
Did you know our New Fellows Program offers botanist led pollen walks for Allergy Fellows? In late July, Sam Wauford, Eastern Regional Sales Manager and botanist, along with Matthew Brennan, Account Executive for NJ/NY/CT, conducted a pollen walk for eight Allergy Fellows in training from Montifiore Medical Center, Bronx, NY. Finding weeds in the urban…
Details
Venom Immunotherapy Supply Update
One year ago, we announced that our company had become the sole provider of venom immunotherapy products in the U.S.—a position brought about by the departure from the market of the only other supplier. In the ensuing year, we have committed all of our resources to ensuring a long-term, consistent supply of venom products for our customers. We’re pleased to share with you this brief overview of what we’ve been working on, and advances CMS has made with reimbursements.
Details
BeeAware Allergy Relaunches
New Year • New Program For nearly a decade, HollisterStier Allergy’s BeeAware program has helped educate patients and physicians about venom immunotherapy. We are excited to announce the roll-out of our refreshed BeeAware program and the launch of a fresh and updated website. Patient education delivered in a new and improved package The BeeAware program…
Details
Venom Immunotherapy Supplies
Read as letter Read related AAAAI/ACAAI email to members At the end of February 2018, we learned that we will be the only supplier of venom immunotherapy products in North America. In light of this situation, we have evaluated our production capabilities as they relate to our ability to indefinitely supply the entire North American…
Details
Man’s best friend
It may be AP Dog if he’s allergic to his canine companion. According to the U.S. Pet Ownership & Demographics Sourcebook (2012), there is at least one dog living in over 36 percent of US households. That translates to 43,346,000 homes with at least one dog in residence. While only 10 percent1 of people are allergic to them,…
Details
Chris Preti Joins Company as President
January 22, 2018 – Jubilant Pharma announces the appointment of Chris Preti to the position of President for its allergy company, HollisterStier Allergy. Mr. Preti has over 25 years of progressive pharmaceutical experience. He began his career at GlaxoSmithKline in research and development, developing products for regulatory submission across multiple therapeutic areas. He then joined…
Details
AAAAI | ACAAI Venom Extract Shortage Task Force Report
Joint Message Announcing Venom Extract Shortage Task Force Report The AAAAI and ACAAI previously announced a venom extract shortage due to ALK – Abello A/S experiencing a manufacturing delay in regards to its venom products. In response, we formed a task force of experts to generate guidance outlining recommendations for our members which could lead…
Details